Aeterna Zentaris (NASDAQ and TSX: AEZS) said Friday that it has finalized certain details regarding the previously reported merger with Ceapro (CZO.V).
On May 3, Aeterna completed a share consolidation of one post-consolidation common share for every four pre-consolidation common shares. As a result, the exchange ratio to be used in connection with the issuance of common shares to Ceapro shareholders under the transaction has been adjusted. On closing of the deal, Ceapro shareholders will now receive 0.02360 of a common share for each Ceapro share held.
As of the close of business on May 29, the common shareholders will receive 0.47698 of a common share purchase warrant on May 31 for each post-consolidation common share.
The Toronto Stock Exchange and Nasdaq have determined that the common shares will trade on a due bill basis from the opening of markets on May 29 to May 31, inclusive.
Ex-distribution trading in the common shares will begin as of the opening of markets on June 3, as of which date purchases of common shares will no longer have the attaching entitlement to transaction warrants. The due bill redemption date will be June 4.
The deal is expected to close by June 3.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。